[Clinical studies of T-1982 (cefbuperazone) in the field of pediatrics]. 1983

N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya

T-1982 (cefbuperazone), a new cephamycin antibiotic, was clinically and bacteriologically studied in 25 children with bacterial infections. The following results were obtained. 1. The antibacterial activity of T-1982 was determined against clinically isolated bacteria. T-1982 demonstrated excellent activity against Gram-negative bacilli, the MICs being less than 0.39 microgram/ml against E. coli and K. oxytoca, less than 1.56 microgram/ml against H. influenzae. 2. Clinical response was excellent or good in all 24 cases evaluated. The efficacy rate was 100%. 3. As for side effects associated with T-1982, slight and transient elevation of GOT, GPT and eosinophil, slight decrease of platelet and eruption were observed. From these results, T-1982 is considered to be a useful antibiotic for treating bacterial infections in children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial

Related Publications

N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
May 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
April 1983, The Japanese journal of antibiotics,
N Watanabe, and K Kida, and H Matsuda, and M Murase, and J Ishikawa, and M Ichinomiya
May 1983, The Japanese journal of antibiotics,
Copied contents to your clipboard!